Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia

Glanzmann’s thrombasthenia (GT) is a congenital qualitative platelet disorders due to the deficiency or defect of platelet membrane GPIIb/IIIa (integrin α(IIb)β(3)). The standard treatment for bleeding is platelet transfusion but repeated transfusion may result in the development of anti-platelet an...

Descripción completa

Detalles Bibliográficos
Autor principal: Poon, Man-Chiu
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291310/
https://www.ncbi.nlm.nih.gov/pubmed/18078017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291310/
https://www.ncbi.nlm.nih.gov/pubmed/18078017

Ejemplares similares